ReSPECT-GBM Clinical Trial Update: Phase 2 Enrollment Now Open

We are excited to announce that enrollment for the Phase 1 ReSPECT-GBM clinical trial is complete! We are actively enrolling patients for Phase 2 of the trial, which focuses on treating recurrent glioblastoma (GBM) with advanced targeted radiotherapy.

How to Participate

Physicians with eligible patients are encouraged to refer them for potential participation. Learn more about inclusion criteria and submit an inquiry here:
🔗 ReSPECT-GBM Clinical Trial Information

#Glioblastoma #GBM #BrainCancer #ClinicalTrials #NeuroOncology #Radiotherapy #CancerResearch